Welcome, Guest. Please login or register.
November 21, 2024, 05:13:11 am

Login with username, password and session length


Members
Stats
  • Total Posts: 55133
  • Total Topics: 4851
  • Online Today: 191
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 0
Guests: 193
Total: 193

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: New MRI Contrast Dye Better Detects Early-Stage Liver Disease  (Read 11819 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
New MRI Contrast Dye Better Detects Early-Stage Liver Disease
« on: November 20, 2019, 11:24:01 am »
Researchers have developed a new, safer, more sensitive MRI dye for diagnosing liver disease in its early stages. If more advanced testing of the dye goes well and it is approved by the Food and Drug Administration, it could become a new noninvasive method for detecting such disease, a much-needed alternative to invasive surgical biopsies.

The research team, which published its findings in Nature Communications, was led by Jenny Yang, a regents’ professor in chemistry at Georgia State University and the associate director of the university’s Center for Diagnostics and Therapeutics. The investigation was supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), which is a division of the National Institutes of Health, as well as by Yang’s start-up company, InLighta BioSciences. Investigators at Emory University also contributed.

Read more...
https://www.hepmag.com/article/new-mri-contrast-dye-better-detects-earlystage-liver-disease

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.